These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 31682266)

  • 1. Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis.
    Spindle TR; Cone EJ; Kuntz D; Mitchell JM; Bigelow GE; Flegel R; Vandrey R
    J Anal Toxicol; 2020 Mar; 44(2):109-125. PubMed ID: 31682266
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urinary Pharmacokinetic Profile of Cannabidiol (CBD), Δ9-Tetrahydrocannabinol (THC) and Their Metabolites following Oral and Vaporized CBD and Vaporized CBD-Dominant Cannabis Administration.
    Sholler DJ; Spindle TR; Cone EJ; Goffi E; Kuntz D; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    J Anal Toxicol; 2022 May; 46(5):494-503. PubMed ID: 34089060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary Excretion Profile of Cannabinoid Analytes Following Acute Administration of Oral and Vaporized Cannabis in Infrequent Cannabis Users.
    Sholler DJ; Zamarripa CA; Spindle TR; Martin EL; Kuntz D; Vandrey R; Grabenauer M
    J Anal Toxicol; 2022 Oct; 46(8):882-890. PubMed ID: 35770374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic Profile of ∆9-Tetrahydrocannabinol, Cannabidiol and Metabolites in Blood following Vaporization and Oral Ingestion of Cannabidiol Products.
    Bergeria CL; Spindle TR; Cone EJ; Sholler D; Goffi E; Mitchell JM; Winecker RE; Bigelow GE; Flegel R; Vandrey R
    J Anal Toxicol; 2022 Jul; 46(6):583-591. PubMed ID: 35438179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary Excretion Profile of 11-Nor-9-Carboxy-Δ9-Tetrahydrocannabinol (THCCOOH) Following Smoked and Vaporized Cannabis Administration in Infrequent Cannabis Users.
    Spindle TR; Cone EJ; Schlienz NJ; Mitchell JM; Bigelow GE; Flegel R; Hayes E; Vandrey R
    J Anal Toxicol; 2020 Jan; 44(1):1-14. PubMed ID: 31095692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free and Glucuronide Urine Cannabinoids after Controlled Smoked, Vaporized and Oral Cannabis Administration in Frequent and Occasional Cannabis Users.
    Huestis MA; Sempio C; Newmeyer MN; Andersson M; Barnes AJ; Abulseoud OA; Blount BC; Schroeder J; Smith ML
    J Anal Toxicol; 2020 Oct; 44(7):651-660. PubMed ID: 32369162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic effects of vaporized and oral cannabidiol (CBD) and vaporized CBD-dominant cannabis in infrequent cannabis users.
    Spindle TR; Cone EJ; Goffi E; Weerts EM; Mitchell JM; Winecker RE; Bigelow GE; Flegel RR; Vandrey R
    Drug Alcohol Depend; 2020 Jun; 211():107937. PubMed ID: 32247649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Free and Glucuronide Whole Blood Cannabinoids' Pharmacokinetics after Controlled Smoked, Vaporized, and Oral Cannabis Administration in Frequent and Occasional Cannabis Users: Identification of Recent Cannabis Intake.
    Newmeyer MN; Swortwood MJ; Barnes AJ; Abulseoud OA; Scheidweiler KB; Huestis MA
    Clin Chem; 2016 Dec; 62(12):1579-1592. PubMed ID: 27899456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cannabinoid disposition in oral fluid after controlled smoked, vaporized, and oral cannabis administration.
    Swortwood MJ; Newmeyer MN; Andersson M; Abulseoud OA; Scheidweiler KB; Huestis MA
    Drug Test Anal; 2017 Jun; 9(6):905-915. PubMed ID: 27647820
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of Cannabidiol, ∆9- and ∆8-Tetrahydrocannabinol and Metabolites in Workplace Drug Testing Urine Specimens.
    Vikingsson S; Winecker RE; Cone EJ; Kuntz DJ; Dorsey B; Jacques M; Senter M; Flegel RR; Hayes ED
    J Anal Toxicol; 2022 Oct; 46(8):866-874. PubMed ID: 35260906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral fluid cannabinoids in chronic, daily Cannabis smokers during sustained, monitored abstinence.
    Lee D; Milman G; Barnes AJ; Goodwin RS; Hirvonen J; Huestis MA
    Clin Chem; 2011 Aug; 57(8):1127-36. PubMed ID: 21677094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Δ
    Arkell TR; Kevin RC; Stuart J; Lintzeris N; Haber PS; Ramaekers JG; McGregor IS
    Drug Test Anal; 2019 Oct; 11(10):1486-1497. PubMed ID: 31442003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. THC and CBD concentrations in blood, oral fluid and urine following a single and repeated administration of "light cannabis".
    Pacifici R; Pichini S; Pellegrini M; Rotolo MC; Giorgetti R; Tagliabracci A; Busardò FP; Huestis MA
    Clin Chem Lab Med; 2020 Apr; 58(5):682-689. PubMed ID: 30956228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can oral fluid cannabinoid testing monitor medication compliance and/or cannabis smoking during oral THC and oromucosal Sativex administration?
    Lee D; Karschner EL; Milman G; Barnes AJ; Goodwin RS; Huestis MA
    Drug Alcohol Depend; 2013 Jun; 130(1-3):68-76. PubMed ID: 23146820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of five distinct commercially available hemp-derived topical cannabidiol products.
    Zamarripa CA; Tilton HE; Lin S; Cone EJ; Winecker RE; Flegel RR; Kuntz D; Beals M; Jacques M; Clark M; Welsh ER; Wagner L; Bonn-Miller MO; Vandrey R; Spindle TR
    J Anal Toxicol; 2024 Mar; 48(2):81-98. PubMed ID: 38217086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of cannabinoids in urine, oral fluid and hair samples after repeated intake of CBD-rich cannabis by smoking.
    Gerace E; Bakanova SP; Di Corcia D; Salomone A; Vincenti M
    Forensic Sci Int; 2021 Jan; 318():110561. PubMed ID: 33172758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimization of recombinant β-glucuronidase hydrolysis and quantification of eight urinary cannabinoids and metabolites by liquid chromatography tandem mass spectrometry.
    Sempio C; Scheidweiler KB; Barnes AJ; Huestis MA
    Drug Test Anal; 2018 Mar; 10(3):518-529. PubMed ID: 28815938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of cannabinoids in oral fluid and urine of "light cannabis" consumers: a pilot study.
    Pacifici R; Pichini S; Pellegrini M; Tittarelli R; Pantano F; Mannocchi G; Rotolo MC; Busardò FP
    Clin Chem Lab Med; 2018 Dec; 57(2):238-243. PubMed ID: 30332386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlation of creatinine- and specific gravity-normalized free and glucuronidated urine cannabinoid concentrations following smoked, vaporized, and oral cannabis in frequent and occasional cannabis users.
    Huestis MA; Blount BC; Milan DF; Newmeyer MN; Schroeder J; Smith ML
    Drug Test Anal; 2019 Jul; 11(7):968-975. PubMed ID: 30756523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabinoids and metabolites in expectorated oral fluid following controlled smoked cannabis.
    Milman G; Schwope DM; Gorelick DA; Huestis MA
    Clin Chim Acta; 2012 Apr; 413(7-8):765-70. PubMed ID: 22285315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.